증권
Dow Jones Futures: Will The Market Rally Take Flight? Robinhood, Sandisk, AMD, Moderna Surge Into Buy AreasNasdaq rises for week but Dow and Russell 2000 are notable losers.
Is Markel the New Berkshire Hathaway Blueprint for Value Investors Post-Buffett?Warren Buffett's exit from Berkshire Hathaway reignited a debate value investors have circled for years: whether one smaller insurer running the same three-engine compounding model can fill the void, and whether its recent struggles make it a trap or an opportunity.
The Bond Market is Back. Here’s What TLT Bagholders Need to Know.Why bonds and bills are pretty chill for this risk-managed investor.
History Says This Investment Strategy Can Build a $1 Million Portfolio. Here's How.With enough time, discipline, and consistency, this strategy can get most people to the $1 million mark.
What Will $5,000 Invested in Palantir Stock Be Worth in 5 Years?Palantir just posted revenue growth above 90% year-over-year with a Rule of 40 score that has Wall Street rubbing its eyes, yet the five-year model tells a far more complicated story than the bull hype suggests.
Every New Reactor Needs Fuel: 3 Uranium Stocks Positioned for the Nuclear BuildoutUranium mining sits at the narrow end of the funnel feeding the AI-driven reactor buildout, and three US-listed juniors are racing to fill a supply gap that utilities cannot contract their way out of. Not all three are equally close to producing a single pound.
Wall Street’s Favorite Safe Haven Could Be In Trouble. How Investors Should Play Gold Here.Here's what I'm looking at when it comes to gold, Wall Street's favorite "safe haven" asset.
Dave Ramsey Told 1 Caller, ‘Hold on to the Cash. We’re Not Gonna Pay Off the House,’ But 5 Months Later Told Another to Pay It Off That Night. Here’s Why.One caller had just been laid off and expected to move. The other was employed, staying put, and holding about $346,000 in cash and securities against a $280,000 balance.
Amgen or Merck: Which Drugmaker Has the Stronger Dividend Growth Story?Both Amgen and Merck write quarterly checks and raise them every year, but only one has the portfolio depth to keep growing that payout through the next brutal round of patent expirations. The answer may surprise investors who have been watching Merck's blockbuster momentum.
Is Micron's 9% Dip a Warning Sign or Buying Opportunity?Industrywide concerns about AI development affected Micron this week.
John Ternus's First iPhone Launch Prompted a Bank of America Price Target Cut. Is Apple Stock a Buy?Apple stock just got a price target cut due to the memory processor crunch.
Aflac’s (AFL) Net Earnings Jumped 37.7%, Yet Adjusted Earnings Actually FellOn August 6, Aflac (NYSE:AFL) reported second-quarter numbers that point in opposite directions. Net earnings climbed to $825 million, helped along by investment losses that shrank to $153 million from $421 million a year ago. Adjusted earnings, though, fell 7.7% to $883 million. Both numbers are real, but they answer different questions. Which measure you […]
Cencora (COR) Raised Guidance and Bought Back $1B. What’s the Catch?On August 5, Cencora (NYSE:COR) reported results for its fiscal third quarter, which closed on June 30, and the headline numbers looked clean. Revenue rose 5.1% to $84.8 billion, adjusted earnings per share climbed 12.0% to $4.48, and management raised its full-year adjusted EPS outlook to $17.75 to $17.95. The company also repurchased $1 billion […]
Coherent (COHR) Squeezes Key Optical Network Gear Into a Plug-In ModuleOn September 17, Coherent Corp. (NYSE:COHR) announced an upgraded Pluggable Optical Line System that covers the full C-band and fits in a compact QSFP module, the same slot ordinary transceivers use. That is a lot of networking gear shrunk into a plug, and it follows a quarter of 34% revenue growth. Here is what the […]
These 3 Agentic AI Stocks Have More Than Hype Behind Their Growth StoriesServiceNow, UiPath, and Palo Alto Networks show real agentic AI traction through earnings growth, enterprise adoption, and partnerships, making their fundamentals worth watching amid market volatility.
What History Reveals About Investing Through a Stock Market CrashWhat would have happened if you invested in the S&P 500 right before two of the worst market crashes in recent history?
Gallagher’s (AJG) Colorado Deal Is Another Brick in a Very Big WallOn September 15, Arthur J. Gallagher & Co. (NYSE:AJG) announced that it had bought McMillan Insurance & Bonding Inc., an Englewood, Colorado, firm that operates as Innovise Business Consultants. Gallagher did not say what it paid. On its own, the deal is a footnote. But it is one of many, and the way those deals […]
Stock Market Week Ahead: Keeping An Eye Out For ChangeThe stock market continues sideways, but with some optimistic moves that suggest the coming week could be a week of change.
Mitt Romney warned a billionaire tax triggers demand for 2 assets — now California decides. Get in before the super-richCalifornia's Prop 40 would tax billionaire wealth at 5%.
Meta Stock Could Hit $800 This Year -- And It All Begins on Sept. 23Citi sees Meta rising 19% on its Connect event, but the real question is whether AI spending is finally boosting the ad business.